Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05683925

Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Characteristics in Parkinson's Disease

Conditions: Parkinson Disease, Gait Disorders, Neurologic

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 30
Sponsor: University Medical Centre Ljubljana

Location: Slovenia

Summary

In this randomised placebo-controlled trial, the investigators will include 30 PD (Parkinson's disease) patients with HY (Hoehn Yahr stage) >2 and L-dopa unresponsive gait characteristics. Each participant will receive taVNS at 25Hz, taVNS at 100Hz and sham VNS (sVNS). During each stimulation, different gait characteristics will be measured with wearable insertion motion sensors.

Eligibility Criteria

Inclusion Criteria:HYstage >2L-dopa unresponsive gait characteristics present, preferably with history of freezingsExclusion Criteria:unable to walk for 50munable to follow simple commands due to hearing loss/cognitive impairment

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05683925). StuddyBuddy aggregates publicly available trial information.